Blackbaud

BLKB · NASDAQ

$53.57+$0.33 (+0.62%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $53.24

BLKB analyst rating

HoldConsensus of 3 analysts over the last 12 months. 33% rate it a buy.

Strong buy0
Buy1
Hold2
Underperform0
Sell0

12-month price target · 7 analysts

Average $55.31 (+3.2% upside)

Low: $45.45
Now: $53.57
High: $68.37

Upgrades and downgrades

The latest rating actions, newest first

BLKB analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Baird	Sep 15, 2026	Maintains	Outperform	$54.00 → $58.00	52%
Evercore ISI Group	Jul 30, 2026	Maintains	In-Line	$45.00 → $48.00	59%
Stifel	Jul 10, 2026	Maintains	Hold	$45.00 → $30.00	38%
Evercore ISI Group	Apr 30, 2026	Maintains	In-Line	$55.00 → $45.00	59%
Baird	Apr 30, 2026	Upgrade	Neutral → Outperform	$60.00 → $50.00	52%
Stifel	Apr 28, 2026	Maintains	Hold	$50.00 → $45.00	38%
Evercore ISI Group	Feb 11, 2026	Maintains	In-Line	$80.00 → $55.00	59%

The case for and against

Updated Oct 19, 2025

Bull case

Blackbaud is positioned for positive growth due to its successful focus on transactional recurring revenue, which contributed positively during the quarter. The company has taken steps to enhance operational flexibility, coupled with its end markets increasingly adopting digital solutions, which evoke prospects for long-term profitable growth. Additionally, Blackbaud's maintenance of its full-year guidance, projecting approximately 5% organic revenue growth and continued EBITDA margin expansion, underscores its stability and potential for sustained performance.

Bear case

Blackbaud faces significant risks due to a potential reduction in nonprofit donations stemming from a recessionary environment, increased competition, and challenges related to product integration and talent acquisition. Although total revenue experienced a 3.1% decline, non-GAAP organic revenue demonstrated a positive growth of 5.9% when adjusted for divestitures and currency fluctuations. The financial health of the company remains precarious, highlighted by an adjusted EBITDA margin of 34.3%, which may not be sufficient to offset the underlying challenges that threaten profitability and long-term stability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.